Recombinant microorganism including genetic modification that increases activity of nitric oxide reductase and method of reducing concentration of nitric oxide in sample by using the same

US12545932B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12545932-B2
Application numberUS-202117224596-A
CountryUS
Kind codeB2
Filing dateApr 7, 2021
Priority dateNov 25, 2020
Publication dateFeb 10, 2026
Grant dateFeb 10, 2026

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A recombinant microorganism including a genetic modification that increases activity of nitric oxide reductase in the recombinant microorganism, a composition for reducing a concentration of nitric oxide in a sample, the composition including the recombinant microorganism, and a method of reducing a concentration of nitric oxide in a sample, are disclosed.

First claim

Opening claim text (preview).

What is claimed is: 1 . A recombinant bacterium comprising a genetic modification that increases expression of a gene encoding a nitric oxide reductase in the recombinant bacterium, wherein the recombinant bacterium belongs to the genus Escherichia or the genus Paracoccus , wherein the gene originates from Paracoccus versutus and wherein the nitric oxide reductase comprises a polypeptide having 95% or greater sequence identity to a polypeptide encoded by SEQ ID NO:21. 2 . A composition for reducing a concentration of nitric oxide in a sample, the composition comprising the recombinant bacterium according to claim 1 . 3 . A method of reducing a concentration of nitric oxide in a sample containing nitric oxide, the method comprising contacting the sample with the recombinant bacterium according to claim 1 . 4 . The method of claim 3 , wherein the genetic modification increases the copy number of the gene encoding the nitric oxide reductase. 5 . The method of claim 3 , wherein the nitric oxide (NO) is in a form of Fe(II)(L)—NO, which is a complex formed by chelating a chelating agent L with Fe 2+ and NO. 6 . The method of claim 3 , wherein the contacting is performed in a sealed container. 7 . The method of claim 3 , wherein the contacting comprises culturing or incubating the recombinant bacterium in the presence of the nitric oxide-containing sample. 8 . The method of claim 3 , wherein the contacting comprises culturing the recombinant bacterium in a sealed container and under conditions in which the recombinant bacterium grows. 9 . The recombinant bacterium of claim 1 , wherein the genetic modification increases the copy number of the gene encoding the nitric oxide reductase. 10 . The method of claim 3 , wherein the sample is in a liquid state or gas state.

Assignees

Inventors

Classifications

  • C12N9/0044Primary

    acting on other nitrogen compounds as donors (1.7) · CPC title

  • Bacteria; Culture media therefor · CPC title

  • Nitric-oxide reductase (cytochrome c)(1.7.2.5) · CPC title

  • Biological processes · CPC title

  • Enzymatic · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12545932B2 cover?
A recombinant microorganism including a genetic modification that increases activity of nitric oxide reductase in the recombinant microorganism, a composition for reducing a concentration of nitric oxide in a sample, the composition including the recombinant microorganism, and a method of reducing a concentration of nitric oxide in a sample, are disclosed.
Who is the assignee on this patent?
Samsung Electronics Co Ltd
What technology area does this patent fall under?
Primary CPC classification C12N9/0044. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).